UWorld Step 1 Qbank: Your world of learning. Subscribe now.

NBME Answers

free120/Block 1/Question#18
A 62-year-old woman comes to the physician ...
Decreased osteoclast activity🔍

Login to comment/vote.


Bisphosphonates work by decreasing osteoclast activity (thereby reducing bone resorption). “Increased receptor activation of NFkB ligand (RANKL) production” is the opposite of how estrogen therapy works (RANKL is found on osteoblasts, and its activation triggers osteoclasts and stimulates bone resorption).




UWorld Step 1 Qbank: Your world of learning. Subscribe now.